Machine Learning: a Useful Radiological Adjunct in Determination of a Newly Diagnosed Glioma's Grade and IDH Status
Overview
Authors
Affiliations
Introduction: Machine learning methods have been introduced as a computer aided diagnostic tool, with applications to glioma characterisation on MRI. Such an algorithmic approach may provide a useful adjunct for a rapid and accurate diagnosis of a glioma. The aim of this study is to devise a machine learning algorithm that may be used by radiologists in routine practice to aid diagnosis of both: WHO grade and IDH mutation status in de novo gliomas.
Methods: To evaluate the status quo, we interrogated the accuracy of neuroradiology reports in relation to WHO grade: grade II 96.49% (95% confidence intervals [CI] 0.88, 0.99); III 36.51% (95% CI 0.24, 0.50); IV 72.9% (95% CI 0.67, 0.78). We derived five MRI parameters from the same diagnostic brain scans, in under two minutes per case, and then supplied these data to a random forest algorithm.
Results: Machine learning resulted in a high level of accuracy in prediction of tumour grade: grade II/III; area under the receiver operating characteristic curve (AUC) = 98%, sensitivity = 0.82, specificity = 0.94; grade II/IV; AUC = 100%, sensitivity = 1.0, specificity = 1.0; grade III/IV; AUC = 97%, sensitivity = 0.83, specificity = 0.97. Furthermore, machine learning also facilitated the discrimination of IDH status: AUC of 88%, sensitivity = 0.81, specificity = 0.77.
Conclusions: These data demonstrate the ability of machine learning to accurately classify diffuse gliomas by both WHO grade and IDH status from routine MRI alone-without significant image processing, which may facilitate usage as a diagnostic adjunct in clinical practice.
Wei R, Lu S, Lai S, Liang F, Zhang W, Jiang X J Cancer Res Clin Oncol. 2024; 150(2):73.
PMID: 38305926 PMC: 10837235. DOI: 10.1007/s00432-023-05603-3.
Bhandari A, Scott L, Weilbach M, Marwah R, Lasocki A Neuroradiology. 2023; 65(5):907-913.
PMID: 36746792 PMC: 10105653. DOI: 10.1007/s00234-023-03126-9.
Jing H, Yang F, Peng K, Qin D, He Y, Yang G Biomed Res Int. 2022; 2022:4667117.
PMID: 36246986 PMC: 9553483. DOI: 10.1155/2022/4667117.
Challenges and opportunities for advanced neuroimaging of glioblastoma.
Henssen D, Meijer F, Verburg F, Smits M Br J Radiol. 2022; 96(1141):20211232.
PMID: 36062962 PMC: 10997013. DOI: 10.1259/bjr.20211232.
Bahar R, Merkaj S, Cassinelli Petersen G, Tillmanns N, Subramanian H, Brim W Front Oncol. 2022; 12:856231.
PMID: 35530302 PMC: 9076130. DOI: 10.3389/fonc.2022.856231.